ACUTE MYOCARDIAL INFARCTION WITH VITAMIN B12 DEFICIENCY AND MILD HYPERHOMOCYSTEINEMIA: A CASE REPORT AND REVIEW
DOI:
https://doi.org/10.22159/ajpcr.2016.v9i6.13841Abstract
A 38-year old male was diagnosed with acute myocardial infarction (AMI) without a history of any significant clinical conditions. His subjective complaints and objective findings were clearly suggesting an acute ischemic attack along with vitamin B12 deficiency. While managing him for AMI, serology tests for vitamin B12 revealed low levels along with mild elevation of serum homocysteine level. He was managed with thrombolytic agent, β-adrenergic blocker, aspirin, antiplatelet agents, anticoagulants, statin, vitamin B complex and folic acid supplements. The clinical pharmacist intervened by suggesting discontinuation of Clopidogrel as two antiplatelet agents (Clopidogrel and Ticagrelor) were administered along with an anticoagulant, thereby increasing the risk of bleeding in the patient. Clopidogrel was stopped as Ticagrelor is a better antiplatelet agent when given in combination with low dose aspirin. Also, aspirin dose was reduced to enhance the efficacy of Ticagrelor and provide better secondary prevention for vascular diseases.
Downloads
References
J. Selhub. Homocysteine Metabolism. Annual Review of Nutrition, July 1999;19:217-46.
Spence J. et al. Vitamin intervention for stroke prevention trial- An efficacy analysis. 2005; 36: 2409-9.
Nygard O. Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine study. JAMA 1995; 274(19):1526-33.
Jason Litsky, DO, MS, Stephanie M. Meller, BA, Chirdeep Patel, MD. Acute Myocardial Infarction in A Young Patient With Severe Hyperhomocysteinemia Secondary To Pernicious Anemia. Cath Lab Digest. July 2013; 7(21).
Aayash Melhem, Ankit Desai, Marion A Hofmann. Acute myocardial infarction and pulmonary embolism in a young man with pernicious anemia-induced severe hyperhomocysteinemia. Thrombosis Journal; 2009 5(7).
Shital Rathod, Asef Sayyed, Jayesh Mahale, Vijay Gaikwad. Young myocardial infarction: Secondary to vitamin B12 deficiency. International Journal of Recent Trends in Science and Technology, July 2015; 15(3):521-23.
Warkaa-Al-Shankani, Ngham Saeed Tafar, Sunil Roy Narayanan, Anil Kumar Rajappan. Acute Myocardial Infarction In Young Lady Due To VitaminB12 Deficiency Induced Hyperhomocysteinemia. Heart viewsJanuary 2015; 16(1): 25–29.
Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354:407-13.
Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L, Guttormsen AB, Joglekar A, Sayyad MG, Ulvik A, Ueland PM. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr2001; Aug; 74(2):233-41.
Yajnik CS, Deshpande SS, Lubree HG, Naik SS, Bhat DS, Uradey BS et al. Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India 2006; Oct; 54: 775-82
Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res. 2007 Jun; 4(2):143-50.
Kyriakoula Marinou, Charalambos Antoniades, Dimitris Tousoulis, Christos Pitsavos, Giorgos Goumas, Christodoulos Stefanadis; Homocysteine: A Risk Factor for Coronary Artery Disease? Hellenic J Cardiol 2005; 46: 59-67.
Arnon Blijm, M.D., Sacha Lupovitch. P.D., Khaled Khazim, M.D., Aviva Peleg, Marina Gumanovsky, M.D. Homocysteine Levels in Patients with Risk Factors for Atherosclerosis. Clin. Cardiol. 2001; 24: 463-66.
Praveen I, Christopher C. New antiplatelet drugs for acute coronary syndrome. Aust Prescr 2014; 37(6): 182-6.
Medication Guide, Brilanta [Internet]. Food and Drug Administration. Available from: http://www.fda.gov.
Ticagrelor for the treatment of acute coronary syndromes. NICE Guideline; UK; 26 October 2011; Available from: https://www.nice.org.uk.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
